Top Purchase Related
Home
>
Node
>
Subnode

Development in drug control

Marini Bettolo, G.B.

Il Farmaco; Edizione Pratica 26(7): 367-382

1971

ISSN/ISBN: 0430-0912
PMID: 5561802
Document Number: 33259

Document emailed within 1 workday
Secure & encrypted payments

Schleifer, R.; Pol, L. 2017: International Guidelines on Human Rights and Drug Control: A Tool for Securing Women's Rights in Drug Control Policy Health and human rights 19(1): 253-261
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Griffin, K.B. 1968: Development Planning, Population Control and Economic Development and the Common Aid Effort: the development assistance activities of the Organization for Economic Co-operation and Development International Affairs 44(3): 532-533
Griffin, K.B. 1968: Development Planning, Population Control and Economic Development and the Common Aid Effort: the development assistance activities of the Organization for Economic Co-operation and Development International Affairs 44(3): 532-533
Kelloff, G.J.; Crowell, J.A.; Boone, C.W.; Steele, V.E.; Lubet, R.A.; Greenwald, P.; Alberts, D.S.; Covey, J.M.; Doody, L.A.; Knapp, G.G. 1994: Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute Journal of Cellular Biochemistry. Supplement 20: 55-62
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25
Oslet, J. 2007: Drug control in Belgium: a brief history of drug laws (drugs for human use) Journal de Pharmacie de Belgique 62(4): 123-129
Fallani, M.; Monti, M.; Giordani, R.; Sarti, G.; Travisani, D. 1992: Heterosexual transmission of HIV and a control organization model consisting of female subjects at the USL no. 36 Drug Control Service of Lugo Minerva Ginecologica 44(5): 267-270
Niaz, K. 2017: International drug control system and the United Nations General Assembly Special Session (UNGASS) on the world drug problem: an overview Eastern Mediterranean Health Journal 23(3): 143-149
Rutle, O.; Wium, P. 1980: Quality control in general practice. Self control and future development Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 100(5): 292-296
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Thomas, J.W. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues Journal of the American Veterinary Medical Association 207(7): 899-900; Discussion: 902-904
Fox, D.M. 1991: History of drug use and drug control Mount Sinai Journal of Medicine new York 58(5): 403-405; Discussion: 437-442
Askaa, B.; Horwitz, H.; Wøien, V.A.é; Høgberg, L.C.G.; Jürgens, G. 2014: The development from drug to designer drug Ugeskrift for Laeger 176(42)
Apley, M.D. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Practical aspects of flexible labeling in feedlots Journal of the American Veterinary Medical Association 207(7): 901
Scowen, E.F. 1973: Drug control in Europe Minerva Medica 64(17): 885-888
Stack 1996: Local Drug Delivery: the Development of a Drug Delivery Stent Journal of Invasive Cardiology 8(8): 396-397
Barbadoro, E. 1990: The international system of drug control Bollettino Chimico Farmaceutico 129(3): 140-143
Elis, J. 1988: 70 years of drug control in Czechoslovakia Ceskoslovenska Farmacie 37(7): 289-290